Tri Femynor
Product Images NDC 50090-3413

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tri Femynor (NDC 50090-3413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903413)

Tri Femynor tablet blister pack label by A-S Medication Solutions. It includes storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from light. The package contains 28 tablets. The label shows product details like the lot and product number, and directs users to see the package insert for dosing information.*

FDA Label Image

Blister For Pi (Tri Femynor 1)

FDA Label Image

Norgestimate Chem Struc (Tri Femynor 2)

Chemical structure diagram of norgestimate. The image shows the molecular framework with labeled chemical groups including methyl (CH3), acetoxy (OCOCH3), and hydroxylamine (HON) groups, indicating stereochemistry and triple bond features.*

FDA Label Image

Ee Chem Struc (Tri Femynor 3)

Chemical structure diagram of Ethinyl Estradiol, showing its steroid backbone with hydroxyl and ethynyl functional groups, associated with the product Tri Femynor by A-S Medication Solutions.*

FDA Label Image

Patient-info-figure (Tri Femynor 4)

An effectiveness chart categorizing contraceptive methods by pregnancy frequency per 100 women per year. It ranks from fewer pregnancies with implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring, to more pregnancies with no birth control, withdrawal, spermicides, and no sex during fertile days. Condoms and diaphragm are in the middle range.*

FDA Label Image

Blister-pic (Tri Femynor 5)

Dosage and administration guide for Tri Femynor oral contraceptive tablets in a 28-day blister card format. The image shows color-coded daily pills arranged in four rows by week, with arrows indicating the direction to take pills from left to right. Instructional text explains starting the pill series depending on period start day, with days of the week labeled above each pill.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.